Friday, September 24, 2010


Millions of people at risk for severe allergic reactions to certain foods and bee stings rely on pen-sized syringes that contain a life-saving dose of the drug epinephrine to administer in an emergency.

As lifelong allergy sufferers, twin brothers Eric S. Edwards and Evan T. Edwards,co-founders of the Richmond-based specialty pharmaceutical firm Intelliject Inc., keep their epinephrine auto-injectors close by.

As grateful as the brothers are to have the existing injector technology available, from their own experiences they've concluded there has to be a better injector system.

The 29-year-old brothers and their management team have built Intelliject around the goal of creating a more intuitive, compact and safer emergency epinephrine delivery system.

Their result -- a credit card-sized device that "talks" users through administering epinephrine.

Read full article here...